AQP5 and cancer: Using cell lines, mouse models, and human cancer tissue samples, we have recently verified that AQP5 can turn on RAS and AKT activation, which itself carries SH3 binding activities (Kang et al., manuscript submitted; 10, 124, 148, 149).